Becton Dickinson (BDX) Total Non-Current Liabilities (2009 - 2026)

Becton Dickinson (BDX) reported Total Non-Current Liabilities of $24.2 billion for Q1 2026, down 52.91% year-over-year from $51.5 billion in Q1 2025, and down 55.02% quarter-over-quarter from $53.9 billion in Q4 2025.

Becton Dickinson (BDX) Total Non-Current Liabilities (2009 - 2026) Analysis & Trends

Becton Dickinson (BDX) has 18 years of Total Non-Current Liabilities data on file, last reported at $24.2 billion in Q1 2026.

  • Total Non-Current Liabilities for Q1 2026 came in at $24.2 billion, down 52.91% year-over-year; the trailing twelve-month figure through Mar 2026 was $24.2 billion (down 52.91% YoY), and the FY2025 annual result was $27.3 billion, down 27.36% from the prior year.
  • Total Non-Current Liabilities declined to $24.2 billion in Q1 2026 per BDX's latest filing, from $53.9 billion in the prior quarter.
  • Over five years, Total Non-Current Liabilities peaked at $56.1 billion in Q2 2022 and troughed at $24.2 billion in Q1 2026.
  • A 5-year average of $41.4 billion and a median of $49.4 billion in 2022 frame the typical range for Total Non-Current Liabilities.
  • The sharpest annual moves came in 2024 and 2026: Total Non-Current Liabilities soared 84.2% in 2024, then tumbled 52.91% in 2026.
  • A 5-year view of Total Non-Current Liabilities shows it stood at $32.9 billion in 2022, then dropped by 14.49% to $28.1 billion in 2023, then soared by 84.2% to $51.8 billion in 2024, then gained by 4.03% to $53.9 billion in 2025, then slumped by 55.02% to $24.2 billion in 2026.
  • Business Quant data shows BDX's Total Non-Current Liabilities at $24.2 billion in Q1 2026, $53.9 billion in Q4 2025, and $27.3 billion in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Non-Current Liabilities (Qtr)
1 Intuitive Surgical 148.09 Bn 143.69 Bn 1.83 Bn 1.91 Bn
2 Becton Dickinson 41.00 Bn 39.99 Bn 2.15 Bn 24.24 Bn
3 Medline 30.38 Bn 36.22 Bn 1.84 Bn 17.13 Bn
4 Resmed 28.22 Bn 26.56 Bn 890.98 Mn 941.16 Mn
5 West Pharmaceutical Services 23.72 Bn 23.19 Bn 296.40 Mn 1.03 Bn
6 Solventum 13.33 Bn 13.33 Bn 1.10 Bn 8.65 Bn
7 Cooper Companies 13.12 Bn 12.99 Bn 735.40 Mn 3.98 Bn
8 Align Technology 12.86 Bn 11.80 Bn 736.59 Mn 2.10 Bn
9 Baxter International 10.51 Bn 8.47 Bn 891.00 Mn 12.54 Bn
10 Aptargroup 7.72 Bn 7.52 Bn 351.91 Mn 2.44 Bn

Historic Data

Download Data
DateValue
Mar 31, 2026 24.24 Bn
Dec 31, 2025 53.88 Bn
Sep 30, 2025 27.30 Bn
Jun 30, 2025 26.60 Bn
Mar 31, 2025 51.47 Bn
Dec 31, 2024 51.80 Bn
Sep 30, 2024 37.59 Bn
Jun 30, 2024 51.42 Bn
Mar 31, 2024 50.41 Bn
Dec 31, 2023 28.12 Bn
Sep 30, 2023 49.75 Bn
Jun 30, 2023 28.96 Bn
Mar 31, 2023 34.36 Bn
Dec 31, 2022 32.88 Bn
Sep 30, 2022 49.37 Bn
Jun 30, 2022 56.10 Bn
Mar 31, 2022 49.45 Bn
Dec 31, 2021 34.10 Bn
Sep 30, 2021 29.39 Bn
Jun 30, 2021 56.03 Bn